PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:12 AM ET

Sponsor Check › Person

JP
No photo found yet (own website and image search run after this page is viewed)

John Pappajohn

Named as an officer, director or promoter on SEC Form D filings · CA, IA, TX, GA, NJ, MA · Aug 3, 2009 → Jan 8, 2016

10deals (issuers)
$127.5Mreported sold
263investors
41Form D filings
2009–2016years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

John Pappajohn is listed as an executive officer and director on 41 SEC Form D filings by 10 issuers between Aug 2009 and Dec 2022. Largest by amount reported sold: ConnectRN, Inc. (Waltham, MA — other health care — 2017–2021; $75M reported sold to 25 investors), OneroRx, Inc. (West Des Moines, IA — industry reported as "Other" — 2022; $20M reported sold to 75 investors), CANCER GENETICS, INC (Rutherford, NJ — biotechnology — 2010–2017; $10M reported sold to 42 investors), Telemynd, Inc. (Maynard, MA — other health care — 2022; $6M reported sold to 7 investors), Syncbak, Inc. (Marion, IA — industry reported as "Other" — 2013; $5.25M reported sold to 49 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $127.5M sold in total.

Listed alongside Paul Buck (20 shared filings), George Carpenter (19 shared filings), Daniel Hoffman (12 shared filings), David B. Jones (11 shared filings), Geoffrey Harris (11 shared filings) and 76 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.

1 of the issuers belongs to the sponsor group Emmaus Life Sciences (3 issuers, $3.74M reported sold, 2009–2023).

What this means A sponsor group is one team that sets up a new company for each deal. Emmaus Life Sciences has 3 companies on file and $3.74M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 41 public filings for John Pappajohn and found 19 differences, 6 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for John Pappajohn has not run yet — it is #8,855 of 9,661 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched John Pappajohn..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

19 differences found between the filings for John Pappajohn — 6 worth asking about (compared 41 filings on Oct 24, 2026)

Worth asking · Sep 8, 2009 – Mar 17, 2010

Amount sold went down between filings — Emmaus Life Sciences, Inc.

The Sep 8, 2009 filing says $2,043,000 sold; the Mar 17, 2010 Form D says $500,000 sold — $1,543,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Sep 8, 2009 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Worth asking · Mar 17, 2010

Amount sold went down between filings — Emmaus Life Sciences, Inc.

The Mar 17, 2010 filing says $500,000 sold; the Mar 17, 2010 Form D says $200,000 sold — $300,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Mar 17, 2010 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Worth asking · Sep 8, 2009 – Mar 17, 2010

Investor count went down between filings — Emmaus Life Sciences, Inc.

The Sep 8, 2009 filing reports 6 investors; the Mar 17, 2010 Form D reports 2 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Sep 8, 2009 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Worth asking · Mar 17, 2010

Investor count went down between filings — Emmaus Life Sciences, Inc.

The Mar 17, 2010 filing reports 2 investors; the Mar 17, 2010 Form D reports 1 investor.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Mar 17, 2010 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 18, 2010 – Nov 2, 2011

4 paid sellers are listed without a CRD number

Paid seller listed without a CRD number: Monarch Capital Group, Inc. — Emmaus Life Sciences, Inc. · Paid seller listed without a CRD number: CIM Securities, LLC — Emmaus Life Sciences, Inc. · Paid seller listed without a CRD number: Antaeus Capital, Inc. — Emmaus Life Sciences, Inc. · Paid seller listed without a CRD number: Monarch Capital Group LLC — Emmaus Life Sciences, Inc.

What this means Without a CRD number we cannot look a seller up on BrokerCheck. Ask who they are and whether they are registered.

Form D · Nov 2, 2011 ↗BrokerCheck search: Monarch Capital Group, Inc. ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗BrokerCheck search: CIM Securities, LLC ↗
Sources
Worth asking · Mar 30, 2009 – Dec 15, 2022

17 Form Ds were filed more than 15 days after the first sale

Form D filed 82 days after the first sale — CANCER GENETICS, INC · Form D filed 84 days after the first sale — Emmaus Life Sciences, Inc. · Form D filed 167 days after the first sale — CANCER GENETICS, INC · Form D filed 279 days after the first sale — Emmaus Life Sciences, Inc. · Form D filed 307 days after the first sale — Emmaus Life Sciences, Inc. · and 12 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Dec 5, 2016 ↗CANCER GENETICS, INC — PartnerFacts page ↗Form D · Sep 30, 2014 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Note · Dec 11, 2014 – Sep 15, 2015

John Pappajohn's role changed at American CareSource Holdings, Inc.: director → executive officer, director

The Dec 11, 2014 filing lists John Pappajohn as director; the Sep 15, 2015 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Dec 11, 2014 ↗Form D · Sep 15, 2015 ↗John Pappajohn — PartnerFacts page ↗American CareSource Holdings, Inc. — PartnerFacts page ↗
Sources
Note · Sep 8, 2009 – Jan 8, 2016

9 offerings changed their target amount between filings

Offering amount changed between filings — Emmaus Life Sciences, Inc. · Offering amount changed between filings — Emmaus Life Sciences, Inc. · Offering amount changed between filings — Syncbak, Inc. · Offering amount lowered between filings — Emmaus Life Sciences, Inc. · Offering amount lowered between filings — CANCER GENETICS, INC · and 4 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D/A (earlier) · Jul 2, 2015 ↗Form D/A (later) · Jan 8, 2016 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗Form D (earlier) · Sep 30, 2014 ↗
Sources
Note · May 19, 2009 – Jan 7, 2022

15 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Inseer Inc. (latest filing Jan 7, 2022) · No amendment in the last 12 months on an offering that may still be open — ConnectRN, Inc. (latest filing Dec 20, 2021) · No amendment in the last 12 months on an offering that may still be open — ConnectRN, Inc. (latest filing Apr 21, 2021) · No amendment in the last 12 months on an offering that may still be open — Emmaus Life Sciences, Inc. (latest filing Jan 8, 2016) · No amendment in the last 12 months on an offering that may still be open — Emmaus Life Sciences, Inc. (latest filing Sep 30, 2014) · and 10 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jan 7, 2022 ↗Inseer Inc. — PartnerFacts page ↗Form D · Dec 20, 2021 ↗ConnectRN, Inc. — PartnerFacts page ↗
Sources
Note · May 18, 2017 – Dec 20, 2021

Industry group changed between filings — ConnectRN, Inc.

"Other Technology" (May 18, 2017); then "Other Health Care" (Jun 5, 2018); then "Other Technology" (Apr 21, 2021); then "Other Health Care" (Dec 20, 2021).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 18, 2017 ↗Form D · Jun 5, 2018 ↗Form D · Apr 21, 2021 ↗Form D · Dec 20, 2021 ↗
Sources
Note · May 3, 2011

Same name, different state: "John Pappajohn" (NY) is a separate record

This page covers filings where the address state is CA or IA or TX or GA or NJ or MA. A separate record, "John Pappajohn" with address state NY, is listed on 1 filing — most recently by Gate Technologies, LLC (May 3, 2011). Both records have filings in the same period (May 3, 2011).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

John Pappajohn (NY) — PartnerFacts page ↗Form D · May 3, 2011 ↗Gate Technologies, LLC — PartnerFacts page ↗John Pappajohn (CA,IA,TX,GA,NJ,MA) — this page ↗
Sources
Note · Aug 12, 2009 – Nov 19, 2010

Same name, different state: "John Pappajohn" (MD) is a separate record

This page covers filings where the address state is CA or IA or TX or GA or NJ or MA. A separate record, "John Pappajohn" with address state MD, is listed on 2 filings — most recently by PHARMATHENE, INC (Nov 19, 2010). Both records have filings in the same period (Aug 12, 2009 to Nov 19, 2010).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

John Pappajohn (MD) — PartnerFacts page ↗Form D · Nov 19, 2010 ↗PHARMATHENE, INC — PartnerFacts page ↗John Pappajohn (CA,IA,TX,GA,NJ,MA) — this page ↗
Sources
Note · Sep 8, 2009 – Apr 21, 2021

5 address changes between filings

Address moved from Newton, MA to Waltham, MA — ConnectRN, Inc. · Address moved from Auburndale, MA to Newton, MA — ConnectRN, Inc. · Address moved from Washington Dc, DC to Rutherford, NJ — CANCER GENETICS, INC · Address moved from Dallas, TX to Atlanta, GA — American CareSource Holdings, Inc. · Address moved from Costa Mesa, CA to Aliso Viejo, CA — Emmaus Life Sciences, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Jun 5, 2018 ↗Form D · Apr 21, 2021 ↗ConnectRN, Inc. — PartnerFacts page ↗Form D · May 18, 2017 ↗
Sources
Note · Aug 3, 2009 – Dec 16, 2022

John Pappajohn is listed with 6 different address states: CA, IA, TX, GA, NJ, MA

CA on 21 filings (Aug 3, 2009 to Jan 8, 2016); IA on 7 filings (Sep 27, 2010 to Apr 29, 2022); TX on 3 filings (May 9, 2014 to Dec 11, 2014); GA on 1 filing (Sep 15, 2015); NJ on 3 filings (May 25, 2016 to Mar 27, 2017); MA on 6 filings (May 18, 2017 to Dec 16, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Aug 3, 2009 ↗Form D · Sep 27, 2010 ↗Form D · May 9, 2014 ↗Form D · Sep 15, 2015 ↗
Sources
Note · Sep 27, 2010 – Mar 27, 2017

Reported revenue range changed between filings — CANCER GENETICS, INC

"$5,000,001 - $25,000,000" (Sep 27, 2010); then "Decline to Disclose" (Mar 27, 2017).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Sep 27, 2010 ↗Form D · Mar 27, 2017 ↗CANCER GENETICS, INC — PartnerFacts page ↗
Sources
Note · Jun 18, 2010 – Aug 3, 2010

Minimum investment changed between filings — Emmaus Life Sciences, Inc.

The Jun 18, 2010 filing lists a minimum of $500,000; the Aug 3, 2010 Form D/A lists $125,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 18, 2010 ↗Form D/A (later) · Aug 3, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Note · Mar 17, 2010 – Mar 18, 2010

Minimum investment changed between filings — Emmaus Life Sciences, Inc.

The Mar 17, 2010 filing lists a minimum of $200,000; the Mar 18, 2010 Form D lists $1,000,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Mar 17, 2010 ↗Form D (later) · Mar 18, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Note · Sep 8, 2009 – Mar 17, 2010

Minimum investment changed between filings — Emmaus Life Sciences, Inc.

The Sep 8, 2009 filing lists a minimum of $54,000; the Mar 17, 2010 Form D lists $250,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Sep 8, 2009 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
Note · Mar 17, 2010

Minimum investment changed between filings — Emmaus Life Sciences, Inc.

The Mar 17, 2010 filing lists a minimum of $250,000; the Mar 17, 2010 Form D lists $200,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Mar 17, 2010 ↗Form D (later) · Mar 17, 2010 ↗Emmaus Life Sciences, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

6 of 32 offerings report sales commissions totalling $7,736,620; 2 report finder's fees totalling $1,393,500; 3 report proceeds to related persons totalling $1,984,890. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Dec 16, 2022 D/A
Telemynd, Inc.
File 021-467630
$0$0$0None listed on this filingEDGAR ↗
Apr 29, 2022 D
OneroRx, Inc.
File 021-443811
$0$793,500 (est.)$0None listed on this filingEDGAR ↗
Jan 7, 2022 D
Inseer Inc.
File 021-428418
$0$0$0None listed on this filingEDGAR ↗
Dec 20, 2021 D
ConnectRN, Inc.
File 021-425970
$0$0$0None listed on this filingEDGAR ↗
Apr 21, 2021 D
ConnectRN, Inc.
File 021-396550
$0$0$1,046,890None listed on this filingEDGAR ↗
Jun 5, 2018 D
ConnectRN, Inc.
File 021-313867
$0$0$0None listed on this filingEDGAR ↗
May 18, 2017 D
ConnectRN, Inc.
File 021-287056
$0$0$0None listed on this filingEDGAR ↗
Mar 27, 2017 D
CANCER GENETICS, INC
File 021-283388
$0 (est.)$0$0 (est.)
Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3.
None listed on this filingEDGAR ↗
Dec 5, 2016 D
CANCER GENETICS, INC
File 021-275654
$385,000 (est.)$0$0 (est.)
Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3.
H.C. WainWright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
May 25, 2016 D
CANCER GENETICS, INC
File 021-263863
$350,000 (est.)$0$0 (est.)
Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3.
H.C. WainWright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Jan 8, 2016 D/A
Emmaus Life Sciences, Inc.
File 021-225542
$0$0$478,000 (est.)
Working capital including salaries for officers
None listed on this filingEDGAR ↗
Sep 15, 2015 D
American CareSource Holdings, Inc.
File 021-247677
$0$0$0None listed on this filingEDGAR ↗
Dec 11, 2014 D
American CareSource Holdings, Inc.
File 021-229941
$0$0$0None listed on this filingEDGAR ↗
Sep 30, 2014 D
Emmaus Life Sciences, Inc.
File 021-225540
$0$0$0None listed on this filingEDGAR ↗
Sep 4, 2014 D
American CareSource Holdings, Inc.
File 021-224060
$0$0$0None listed on this filingEDGAR ↗
May 9, 2014 D
American CareSource Holdings, Inc.
File 021-217129
$0$0$0None listed on this filingEDGAR ↗
Jan 30, 2014 D
Emmaus Life Sciences, Inc.
File 021-210971
$0$0$0None listed on this filingEDGAR ↗
Sep 17, 2013 D
Emmaus Life Sciences, Inc.
File 021-203013
$0$0$0None listed on this filingEDGAR ↗
Jun 14, 2013 D
Emmaus Life Sciences, Inc.
File 021-198008
$0$0$0None listed on this filingEDGAR ↗
May 22, 2013 D/A
Syncbak, Inc.
File 021-192052
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2013 D
Emmaus Life Sciences, Inc.
File 021-193086
$0$0$0None listed on this filingEDGAR ↗
Dec 14, 2012 D
Emmaus Life Sciences, Inc.
File 021-188439
$0$0$0None listed on this filingEDGAR ↗
Sep 7, 2012 D
Emmaus Life Sciences, Inc.
File 021-183758
$0$0$0None listed on this filingEDGAR ↗
Mar 28, 2012 D
St. Gregory Centers Holdings, LLC
File 021-175766
$0$0$0None listed on this filingEDGAR ↗
Nov 2, 2011 D
Emmaus Life Sciences, Inc.
File 021-168169
$210,000 (est.)$0 (est.)$0Monarch Capital Group, Inc. no CRD number reported
CIM Securities, LLC no CRD number reported		EDGAR ↗
Oct 26, 2011 D
Emmaus Life Sciences, Inc.
File 021-167841
$0$0$0None listed on this filingEDGAR ↗
May 9, 2011 D/A
Emmaus Life Sciences, Inc.
File 021-155547
$105,000 (est.)$0 (est.)$0Monarch Capital Group, Inc. no CRD number reported
Antaeus Capital, Inc. no CRD number reported		EDGAR ↗
Nov 1, 2010 D/A
CANCER GENETICS, INC
File 021-148200
$6,620,620$0$460,000Garden State Securities, Inc. BrokerCheck CRD 10083 ↗
via Portfolio Advisors Alliance, Inc. (CRD 101680 ↗)

Felix Investments, LLC BrokerCheck CRD 148441 ↗
Allen Partners BrokerCheck CRD 36518 ↗
via Portfolio Advisors Alliance, Inc. (CRD 101680 ↗)
EDGAR ↗
Oct 18, 2010 D
Emmaus Life Sciences, Inc.
File 021-149246
$66,000 (est.)$0$0Monarch Capital Group LLC no CRD number reportedEDGAR ↗
Aug 3, 2010 D/A
Emmaus Life Sciences, Inc.
File 021-143748
$0$0$0None listed on this filingEDGAR ↗
Mar 18, 2010 D
Emmaus Life Sciences, Inc.
File 021-134238
$0$0$0None listed on this filingEDGAR ↗
Aug 3, 2009 D
SPECTRASCIENCE INC
File 021-72767-2C
$0$600,000 (est.)$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named John Pappajohn on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

T
Other Health Care

Telemynd, Inc.

Maynard, MA · Dec 15, 2022 → Dec 16, 2022 · 2 filings
  • Dec 16, 2022 · D/A · $6,000,001 sold of $6,000,001 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 15, 2022 · D · $6,000,001 sold of $6,000,001 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $6M from 7 investors (100% of the $6M target) as of the latest filing. John is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

O
Other

OneroRx, Inc.

West Des Moines, IA · Apr 29, 2022
  • Apr 29, 2022 · D · $20,000,000 sold of $20,000,000 · 75 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $20M from 75 investors (100% of the $20M target) as of the latest filing. John is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Other

Inseer Inc.

Iowa City, IA · Jan 7, 2022
  • Jan 7, 2022 · D · $0 sold of Indefinite · 0 investors · min. $100,000 · role: Director EDGAR ↗

Raised $500K from 2 investors as of the latest filing. John is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care

ConnectRN, Inc.

Waltham, MA · May 18, 2017 → Dec 20, 2021 · 4 filings
  • Dec 20, 2021 · D · $75,037,982 sold of $76,037,981 · 25 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 21, 2021 · D · $13,143,672 sold of $13,362,161 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 5, 2018 · D · $11,527,049 sold of $11,527,049 · 23 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 18, 2017 · D · $2,525,000 sold of $2,525,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $75M from 25 investors (99% of the $76M target) as of the latest filing. John is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CG
Biotechnology

CANCER GENETICS, INC

Rutherford, NJ · Sep 27, 2010 → Mar 27, 2017 · 5 filings
  • Mar 27, 2017 · D · $6,000,000 sold of $6,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 5, 2016 · D · $5,500,000 sold of $5,500,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 25, 2016 · D · $5,000,000 sold of $5,000,000 · 41 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 1, 2010 · D/A · $6,618,000 sold of $10,000,000 · 42 investors · min. $10,000 · role: Director EDGAR ↗
  • Sep 27, 2010 · D · $6,618,000 sold of $12,000,000 · 42 investors · min. $10,000 · role: Director EDGAR ↗

Raised $10M from 42 investors (100% of the $6M target) as of the latest filing. John is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EL
Other Health Care · group: Emmaus Life Sciences

Emmaus Life Sciences, Inc.

Torrance, CA · Mar 17, 2010 → Jan 8, 2016 · 20 filings
  • Jan 8, 2016 · D/A · $4,000,000 sold of $6,000,000 · 15 investors · min. $5,000 · role: Director EDGAR ↗
  • Jul 2, 2015 · D/A · $2,265,000 sold of $3,000,000 · 9 investors · min. $5,000 · role: Director EDGAR ↗
  • Sep 30, 2014 · D · $1,550,000 sold of $2,500,000 · 7 investors · min. $5,000 · role: Director EDGAR ↗
  • Sep 30, 2014 · D · $260,000 sold of $1,000,000 · 6 investors · min. $5,000 · role: Director EDGAR ↗
  • Jan 30, 2014 · D · $415,000 sold of $1,000,000 · 9 investors · min. $5,000 · role: Director EDGAR ↗
  • Sep 17, 2013 · D · $221,549 sold of $2,000,000 · 5 investors · min. $5,000 · role: Director EDGAR ↗
  • Jun 14, 2013 · D · $72,500 sold of $2,000,000 · 4 investors · min. $10,000 · role: Director EDGAR ↗
  • Mar 12, 2013 · D · $595,000 sold of $2,500,000 · 16 investors · min. $10,000 · role: Director EDGAR ↗
  • Dec 14, 2012 · D · $135,846 sold of $135,846 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 7, 2012 · D · $300,000 sold of $2,000,000 · 4 investors · min. $50,000 · role: Director EDGAR ↗
  • Nov 2, 2011 · D · $270,000 sold of $2,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 26, 2011 · D · $0 sold of $0 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 9, 2011 · D/A · $2,500,000 sold of $2,500,000 · 12 investors · min. $50,000 · role: Director EDGAR ↗
  • Feb 17, 2011 · D · $450,000 sold of $5,000,000 · 5 investors · min. $50,000 · role: Director EDGAR ↗
  • Oct 18, 2010 · D · $1,611,688 sold of $3,050,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 3, 2010 · D/A · $750,000 sold of $1,000,000 · 3 investors · min. $125,000 · role: Director EDGAR ↗
  • Jun 18, 2010 · D · $500,000 sold of $500,000 · 1 investors · min. $500,000 · role: Director EDGAR ↗
  • Mar 18, 2010 · D · $1,000,000 sold of $1,000,000 · 1 investors · min. $1,000,000 · role: Director EDGAR ↗
  • Mar 17, 2010 · D · $200,000 sold of $400,000 · 1 investors · min. $200,000 · role: Director EDGAR ↗
  • Mar 17, 2010 · D · $500,000 sold of $500,000 · 2 investors · min. $250,000 · role: Director EDGAR ↗

Raised $4M from 19 investors (67% of the $6M target) as of the latest filing. John is listed as director on 20 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AC
Other Health Care

American CareSource Holdings, Inc.

Atlanta, GA · May 9, 2014 → Sep 15, 2015 · 4 filings
  • Sep 15, 2015 · D · $510,000 sold of $510,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 11, 2014 · D · $2,601,600 sold of $2,601,600 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 4, 2014 · D · $2,520,000 sold of $2,520,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 9, 2014 · D · $2,000,000 sold of $2,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.6M from 9 investors (100% of the $510K target) as of the latest filing. John is listed as executive officer, director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Other

Syncbak, Inc.

Marion, IA · Feb 19, 2013 → May 22, 2013 · 2 filings
  • May 22, 2013 · D/A · $2,000,000 sold of $2,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 19, 2013 · D · $1,000,000 sold of $1,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.25M from 49 investors (100% of the $2M target) as of the latest filing. John is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SG
Other Health Care

St. Gregory Centers Holdings, LLC

Des Moines, IA · Mar 28, 2012
  • Mar 28, 2012 · D · $1,000,101 sold of $1,000,101 · 2 investors · min. $100,010 · role: Director (Manager) EDGAR ↗

Raised $1M from 2 investors (100% of the $1M target) as of the latest filing. John is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

S
Biotechnology

SPECTRASCIENCE INC

San Diego, CA · Aug 3, 2009
  • Aug 3, 2009 · D · $930,000 sold of $5,000,000 · 8 investors · min. $25,000 · role: Director EDGAR ↗

Raised $3.15M from 33 investors (63% of the $5M target) as of the latest filing. John is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • John Pappajohn — MD, 1 issuer, Aug 12, 2009 → Nov 19, 2010 · no shared issuer
  • John Pappajohn — NY, 1 issuer, May 3, 2011 → May 3, 2011 · no shared issuer

People around John 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Buck

Executive Officer · 20 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

GC
No photo found yet (own website and image search run after this page is viewed)
Person

George Carpenter

Executive Officer, Director · 19 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel Hoffman

Executive Officer · 12 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

GH
No photo found yet (own website and image search run after this page is viewed)
Person

Geoffrey Harris

Director · 11 shared filings (5 issuers) · also on 1 other issuer

Geoffrey Harris is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David B. Jones

Director · 11 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as John Pappajohn. Their page shows their other deals.

HH
No photo found yet (own website and image search run after this page is viewed)
Person

Henry T. Harbin

Director · 11 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

JV
No photo found yet (own website and image search run after this page is viewed)
Person

Jerome Vaccaro

Director · 10 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

ZM
No photo found yet (own website and image search run after this page is viewed)
Person

Zachary McAdoo

Director · 10 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Turner

Director, Executive Officer · 9 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Darkoch

Executive Officer · 8 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Sassine

Director · 8 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Follman

Director · 8 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

GK
No photo found yet (own website and image search run after this page is viewed)
Person

George Kallins

Director · 7 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

Walter Schindler

Director · 7 shared filings (1 issuer) · also on 4 other issuers

Walter Schindler is on 5 issuers in total — a repeat sponsor. Their page lists every one.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

TOMMY THOMPSON

Director · 6 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Tierney

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Panna L. Sharma

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

RC
No photo found yet (own website and image search run after this page is viewed)
Person

Raju S.K. Chaganti

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew P. Kinley

Director · 5 shared filings (2 issuers) · also on 5 other issuers

Matthew P. Kinley is on 7 issuers in total — a repeat sponsor. Their page lists every one.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Edmund Cannon

Director · 5 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MO
No photo found yet (own website and image search run after this page is viewed)
Person

Mark C. Oman

Director · 4 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Edward B. Berger

Director · 4 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James A. Honn

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

IL
No photo found yet (own website and image search run after this page is viewed)
Person

Idriz Limaj

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MO
No photo found yet (own website and image search run after this page is viewed)
Person

M. Cornelia Outten

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

LL
No photo found yet (own website and image search run after this page is viewed)
Person

Laura L. Little

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MT
No photo found yet (own website and image search run after this page is viewed)
Person

Matthew D. Thompson

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

Howard McLeod

Director · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

FP
No photo found yet (own website and image search run after this page is viewed)
Person

Franklyn G. Prendergast

Director · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Michael J. Welsh

Director · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Jasulavic

Director · 3 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Shelley Boyce

Director · 3 shared filings (2 issuers)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Terry Branstad

Director · 2 shared filings (2 issuers)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Perry

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

AP
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Pecora

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Andrew Pecora is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Riccardo Dalla-Favera

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as John Pappajohn. Their page shows their other deals.

EW
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Wilson

Director · 2 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Brady

Director · 2 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

HS
No photo found yet (own website and image search run after this page is viewed)
Person

Herb Skoog

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

ES
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Scanlon

Director · 2 shared filings (1 issuer)

Listed on the same filings as John Pappajohn. Their page shows their other deals.

The team behind the deals

EL
Sponsor group

Emmaus Life Sciences

3 issuers · 39 filings · $3.74M reported sold · 2009–2023

One team, 3 deal companies. John Pappajohn is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name John Pappajohn.

Same business address

14 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to John Pappajohn by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers John Pappajohn is listed on: none on file. No website or social profile named in OneroRx, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #157,657 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (West Des Moines, IA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Iowa state courts — find the court ↗Texas re:SearchTX court records ↗Georgia state courts — find the court ↗New Jersey state courts — find the court ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Iowa Secretary of State business search ↗Texas Secretary of State business search ↗Georgia Secretary of State business search ↗New Jersey Secretary of State business search ↗Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when John Pappajohn appears on a new Form D, or when a court case or SEC action is matched to them. See plans →